These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Combining antipsychotics; is this strategy useful? Christy J; Burnside D; Agius M Psychiatr Danub; 2014 Nov; 26 Suppl 1():315-21. PubMed ID: 25413558 [TBL] [Abstract][Full Text] [Related]
4. Modafinil effects on behavior and oxidative damage parameters in brain of wistar rats. Ornell F; Valvassori SS; Steckert AV; Deroza PF; Resende WR; Varela RB; Quevedo J Behav Neurol; 2014; 2014():917246. PubMed ID: 25431526 [TBL] [Abstract][Full Text] [Related]
5. Atypical Anti-Psychotics in Adult Bipolar Disorder: Current Evidence and Updates in the NICE guidelines. Poo SX; Agius M Psychiatr Danub; 2014 Nov; 26 Suppl 1():322-9. PubMed ID: 25413559 [TBL] [Abstract][Full Text] [Related]
6. Could modafinil be a drug of dependence? Dhillon R; Wu X; Bastiampillai T; Tibrewal P Aust N Z J Psychiatry; 2015 May; 49(5):485-6. PubMed ID: 25586757 [No Abstract] [Full Text] [Related]
9. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine D₂ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats. Oyamada Y; Horiguchi M; Rajagopal L; Miyauchi M; Meltzer HY Behav Brain Res; 2015 May; 285():165-75. PubMed ID: 25448429 [TBL] [Abstract][Full Text] [Related]
10. Reward processing dysfunction in major depression, bipolar disorder and schizophrenia. Whitton AE; Treadway MT; Pizzagalli DA Curr Opin Psychiatry; 2015 Jan; 28(1):7-12. PubMed ID: 25415499 [TBL] [Abstract][Full Text] [Related]
11. Olanzapine-induced DNA methylation in the hippocampus and cerebellum in genes mapped to human 22q11 and implicated in schizophrenia. Melka MG; Rajakumar N; O'Reilly R; Singh SM Psychiatr Genet; 2015 Apr; 25(2):88-94. PubMed ID: 25415458 [TBL] [Abstract][Full Text] [Related]
12. Second-generation antipsychotic effect on cognition in patients with schizophrenia--a meta-analysis of randomized clinical trials. Nielsen RE; Levander S; Kjaersdam Telléus G; Jensen SO; Østergaard Christensen T; Leucht S Acta Psychiatr Scand; 2015 Mar; 131(3):185-96. PubMed ID: 25597383 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of amisulpride and olanzapine for negative symptoms and cognitive impairments: An open-label clinical study. Kumar S; Chaudhury S Ind Psychiatry J; 2014 Jan; 23(1):27-35. PubMed ID: 25535442 [TBL] [Abstract][Full Text] [Related]
14. Prescribing of antipsychotics in UK primary care: a cohort study. Marston L; Nazareth I; Petersen I; Walters K; Osborn DP BMJ Open; 2014 Dec; 4(12):e006135. PubMed ID: 25524544 [TBL] [Abstract][Full Text] [Related]
15. Personality development and intellectual disability. Roy M; Retzer A; Sikabofori T Curr Opin Psychiatry; 2015 Jan; 28(1):35-9. PubMed ID: 25415494 [TBL] [Abstract][Full Text] [Related]
16. Time to discontinuation of antipsychotic drugs in a schizophrenia cohort: influence of current treatment strategies. Kroken RA; Kjelby E; Wentzel-Larsen T; Mellesdal LS; Jørgensen HA; Johnsen E Ther Adv Psychopharmacol; 2014 Dec; 4(6):228-39. PubMed ID: 25489474 [TBL] [Abstract][Full Text] [Related]